Los puntos clave no están disponibles para este artículo en este momento.
The screening group had significantly lower medical care expenses and showed a significantly better prognosis than the nonscreening group. On the basis of the GDP per capita, the NCSP for gastric cancer was cost-effective for treatment prognosis.
Suh et al. (Fri,) studied this question.